Richard L Wynn1. Show Affiliations » 1. Department of Oral Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA.
Abstract
Mesh： See more » Anticoagulants/adverse effectsAnticoagulants/therapeutic useAntithrombins/adverse effectsAntithrombins/therapeutic useBenzimidazoles/adverse effectsBenzimidazoles/therapeutic useClinical Trials as TopicDabigatranDental Care for Chronically IllFactor Xa InhibitorsHumansMorpholines/adverse effectsMorpholines/therapeutic useOral Hemorrhage/prevention & controlPiperazines/adverse effectsPiperazines/therapeutic usePlatelet Aggregation Inhibitors/adverse effectsPlatelet Aggregation Inhibitors/therapeutic usePrasugrel HydrochloridePurinergic P2Y Receptor Antagonists/adverse effectsPurinergic P2Y Receptor Antagonists/therapeutic useRivaroxabanThiophenes/adverse effectsThiophenes/therapeutic usebeta-Alanine/adverse effectsbeta-Alanine/analogs & derivativesbeta-Alanine/therapeutic use
Substances： See more » AnticoagulantsAntithrombinsBenzimidazolesFactor Xa InhibitorsMorpholinesPiperazinesPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsThiophenesbeta-AlanineRivaroxabanPrasugrel HydrochlorideDabigatran
Year: 2012 PMID： 22313973
Source DB: PubMed Journal: Gen Dent ISSN： 0363-6771